- Recce Pharmaceuticals (RCE) has been awarded a rebate on almost $10 million of research and development (R&D) by AusIndustry
- The award is a big win for Recce as the R&D rebates typically only apply to work done domestically
- The new finding means the company can claim around $11.65 million in rebates for research it's conducting overseasAfter a recent $27.95 million capital raise, the additional rebate funds will provide the company with a substantial funding runway
- The company is planning a number of trials for its suite of synthetic antiviral compounds to fight antibiotic-resistant superbugs and emerging viral pathogens
- Recce Pharmaceuticals is up 0.83 per cent and trading at $1.22
Read the full article on The Market Herald here.
- Forums
- ASX - By Stock
- Recce Pharmaceuticals (ASX:RCE) awarded another big R&D rebate
RCE
recce pharmaceuticals ltd
Add to My Watchlist
1.30%
!
39.0¢

Recce Pharmaceuticals (RCE) has been awarded a rebate on almost...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
39.0¢ |
Change
0.005(1.30%) |
Mkt cap ! $112.0M |
Open | High | Low | Value | Volume |
38.5¢ | 39.0¢ | 38.0¢ | $279 | 729 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5005 | 38.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.0¢ | 49842 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5005 | 0.385 |
2 | 24610 | 0.380 |
5 | 6386 | 0.375 |
2 | 5261 | 0.370 |
2 | 33181 | 0.365 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 49843 | 1 |
0.395 | 261 | 1 |
0.400 | 23365 | 3 |
0.410 | 25471 | 1 |
0.435 | 5115 | 1 |
Last trade - 14.39pm 31/07/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |